Wire Stories
Biocytogen Establishes Two Business Divisions To Distinguish Preclinical Models and Services (BioMice) from Antibody Drug R&D
BEIJING–(BUSINESS WIRE)–#Animal–Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, HKEX: 02315) today announces the official formation of two major business divisions to represent the...